Cancer Clinical Trial -Senhwa Biosciences-CX-4945-07

Treatment Duration Increment and Pharmacodynamic Study of CX-4945 in Patients With Basal Cell Carcinoma (BCC)

Drug

CX-4945

Phase

Phase I

Condition

Basal Cell Carcinoma

Keywords

Hedgehog Pathway Inhibitor